Manufacturing, Liquid Drug Products

Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility

July 02, 2020

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.

Thermo Fisher Scientific to Invest $24 Million to Expand Global Bioproduction Capabilities

November 06, 2019

The company will invest $24 million into its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell-culture media.

Foamix Enters Manufacturing Agreement with ASM Aerosol-Service for Topical Foam Treatment

October 24, 2019

Through the agreement, Foamix will have access to $20 million of financing to fund the commercial launches of the topical treatments.

AuroMedics Pharma Issues Voluntary Recall Due to Glass and Silicone Particulates

August 03, 2018

AuroMedics Pharma issued a voluntary, nationwide recall of two lots of piperacillin and tazobactam for injection, USP 3.375 g due to the presence of particulates identified as glass and silicone material.

Vetter Expands in Asia-Pacific

November 09, 2017

The company has officially opened a local brand office in South Korean to support its existing business in the region.

Lilly to Invest $72 Million for Insulin Manufacturing Upgrade

October 23, 2017

The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.

ICU Medical Recalls 0.9% Sodium Chloride Injection Due to Particulate Matter

July 31, 2017

Stainless-steel particulates were found in one lot of 0.9% Sodium Chloride Injection, USP 1000 mL, prompting the recall to the hospital/user level.

Sartorius Stedim's New Testing Services to Focus on mAbs and biosimilars

May 05, 2017

Operated by BioOutsource, Sartorius’ subsidiary, the Glasgow, UK-based service center will offer physicochemical properties and structural attributes testing and allow clients to perform structural and functional analyses in parallel.

Fusion Proteins Pose Manufacturability Challenges

May 01, 2017

BioPharm International

The unique structures of fusion proteins lead to expression, heterogeneity, and stability issues.

Hospira Announces Voluntary Recall Due to Subpotency and Impurity Levels

December 30, 2014

Hospira issued a voluntary worldwide recall due to confirmed subpotency and elevated impurity levels.